

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 5.28299842 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.57420644 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.57420644 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 4.54137054 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.52031295 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.52031295 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.52031295 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.52031295 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.52031295 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.52031295 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.06946882 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.01538199 |
| 13 | detection of external biotic stimulus (GO:0098581) | 4.00157634 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 3.98383315 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 3.98383315 |
| 16 | response to peptidoglycan (GO:0032494) | 3.82155951 |
| 17 | cellular extravasation (GO:0045123) | 3.80916803 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.78587517 |
| 19 | establishment of skin barrier (GO:0061436) | 3.65628760 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 3.63818520 |
| 21 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.61901061 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.58238255 |
| 23 | skin morphogenesis (GO:0043589) | 3.57682988 |
| 24 | regulation of water loss via skin (GO:0033561) | 3.57382350 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49543143 |
| 26 | detection of biotic stimulus (GO:0009595) | 3.45178653 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.36682547 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.33050200 |
| 29 | positive regulation of vesicle fusion (GO:0031340) | 3.30484067 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.30366262 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.29987487 |
| 32 | leukocyte aggregation (GO:0070486) | 3.20163872 |
| 33 | neutrophil mediated immunity (GO:0002446) | 3.19230504 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.18474947 |
| 35 | macrophage activation (GO:0042116) | 3.15033140 |
| 36 | germinal center formation (GO:0002467) | 3.10278123 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09958684 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06524590 |
| 39 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.04533383 |
| 40 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03508773 |
| 41 | wound healing, spreading of epidermal cells (GO:0035313) | 3.03458485 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01011023 |
| 43 | response to interleukin-15 (GO:0070672) | 2.99773938 |
| 44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99756603 |
| 45 | response to host immune response (GO:0052572) | 2.99756603 |
| 46 | positive regulation of p38MAPK cascade (GO:1900745) | 2.99207715 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98531161 |
| 48 | response to host (GO:0075136) | 2.98531161 |
| 49 | response to host defenses (GO:0052200) | 2.98531161 |
| 50 | protein retention in ER lumen (GO:0006621) | 2.96366257 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93760705 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93363678 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.91076963 |
| 54 | plasma membrane repair (GO:0001778) | 2.90330752 |
| 55 | keratinization (GO:0031424) | 2.90064602 |
| 56 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.89115147 |
| 57 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86872647 |
| 58 | microglial cell activation (GO:0001774) | 2.86739647 |
| 59 | neutrophil activation (GO:0042119) | 2.85610313 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85221655 |
| 61 | hemidesmosome assembly (GO:0031581) | 2.78556607 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 2.75752323 |
| 63 | granulocyte activation (GO:0036230) | 2.73769719 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.73531379 |
| 65 | regulation of necroptotic process (GO:0060544) | 2.72219670 |
| 66 | negative regulation of type 2 immune response (GO:0002829) | 2.69539607 |
| 67 | type I interferon signaling pathway (GO:0060337) | 2.69404545 |
| 68 | cellular response to type I interferon (GO:0071357) | 2.69404545 |
| 69 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69085052 |
| 70 | myeloid leukocyte mediated immunity (GO:0002444) | 2.67372494 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 2.66847281 |
| 72 | response to type I interferon (GO:0034340) | 2.66625843 |
| 73 | peptide cross-linking (GO:0018149) | 2.66025693 |
| 74 | cell adhesion mediated by integrin (GO:0033627) | 2.64631056 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.64116685 |
| 76 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.64116685 |
| 77 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.62601465 |
| 78 | hypotonic response (GO:0006971) | 2.62430705 |
| 79 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62390308 |
| 80 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.61595787 |
| 81 | regulation of macrophage cytokine production (GO:0010935) | 2.58403529 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.57730279 |
| 83 | response to laminar fluid shear stress (GO:0034616) | 2.57155508 |
| 84 | keratinocyte differentiation (GO:0030216) | 2.56313958 |
| 85 | regulation of type 2 immune response (GO:0002828) | 2.56084390 |
| 86 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.54968199 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.54918722 |
| 88 | phospholipid scrambling (GO:0017121) | 2.52792646 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.51777388 |
| 90 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.51265359 |
| 91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.49385491 |
| 92 | multicellular organismal water homeostasis (GO:0050891) | 2.48040069 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45435267 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 2.44905435 |
| 95 | positive regulation of type 2 immune response (GO:0002830) | 2.44516550 |
| 96 | respiratory burst (GO:0045730) | 2.43370681 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 2.43236033 |
| 98 | positive regulation of macrophage cytokine production (GO:0060907) | 2.42974837 |
| 99 | fibroblast migration (GO:0010761) | 2.42821503 |
| 100 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.41789386 |
| 101 | wound healing, spreading of cells (GO:0044319) | 2.41523823 |
| 102 | regulation of p38MAPK cascade (GO:1900744) | 2.41389526 |
| 103 | positive regulation of nuclease activity (GO:0032075) | 2.40292825 |
| 104 | embryonic process involved in female pregnancy (GO:0060136) | 2.39348211 |
| 105 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.37891642 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 2.37063111 |
| 107 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.36655127 |
| 108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.36612690 |
| 109 | defense response to protozoan (GO:0042832) | 2.36117954 |
| 110 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.36078972 |
| 111 | regulation of ruffle assembly (GO:1900027) | 2.36048981 |
| 112 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.35851671 |
| 113 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.34948884 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 2.33796811 |
| 115 | cellular response to vitamin D (GO:0071305) | 2.33595867 |
| 116 | protein targeting to plasma membrane (GO:0072661) | 2.33260030 |
| 117 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.32770582 |
| 118 | negative regulation of fatty acid transport (GO:2000192) | 2.32281283 |
| 119 | myeloid leukocyte activation (GO:0002274) | 2.32045083 |
| 120 | positive regulation of heat generation (GO:0031652) | 2.31184048 |
| 121 | intermediate filament organization (GO:0045109) | 2.30855080 |
| 122 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.30022962 |
| 123 | cellular response to vitamin (GO:0071295) | 2.29131850 |
| 124 | negative regulation of interleukin-17 production (GO:0032700) | 2.29051463 |
| 125 | regulation of platelet aggregation (GO:0090330) | 2.28224139 |
| 126 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.27042865 |
| 127 | regulation of tolerance induction (GO:0002643) | 2.26530464 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.26145673 |
| 129 | T-helper 1 type immune response (GO:0042088) | 2.25451901 |
| 130 | positive regulation of receptor recycling (GO:0001921) | 2.25418856 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.25225058 |
| 132 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.25191741 |
| 133 | response to gravity (GO:0009629) | 2.25090220 |
| 134 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.25063597 |
| 135 | regulation of regulated secretory pathway (GO:1903305) | 2.24331278 |
| 136 | epithelial cell-cell adhesion (GO:0090136) | 2.22404113 |
| 137 | macroautophagy (GO:0016236) | 2.20215901 |
| 138 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.19907205 |
| 139 | activation of protein kinase A activity (GO:0034199) | 2.19494005 |
| 140 | keratinocyte proliferation (GO:0043616) | 2.18975352 |
| 141 | growth hormone receptor signaling pathway (GO:0060396) | 2.18373789 |
| 142 | water homeostasis (GO:0030104) | 2.17503551 |
| 143 | negative regulation of stress fiber assembly (GO:0051497) | 2.16166956 |
| 144 | cellular response to unfolded protein (GO:0034620) | 2.16153775 |
| 145 | synaptic vesicle maturation (GO:0016188) | 2.15759915 |
| 146 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.14207072 |
| 147 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.13959663 |
| 148 | ER-nucleus signaling pathway (GO:0006984) | 2.13604443 |
| 149 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.13327940 |
| 150 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.12687666 |
| 151 | regulation of fever generation (GO:0031620) | 2.12540732 |
| 152 | vesicle coating (GO:0006901) | 2.10598840 |
| 153 | apoptotic cell clearance (GO:0043277) | 2.09685467 |
| 154 | regulation of nuclease activity (GO:0032069) | 2.09521539 |
| 155 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.09203988 |
| 156 | response to corticosterone (GO:0051412) | 2.07954320 |
| 157 | positive regulation of hair follicle development (GO:0051798) | 2.07292002 |
| 158 | positive regulation of hair cycle (GO:0042635) | 2.07292002 |
| 159 | membrane budding (GO:0006900) | 2.05035162 |
| 160 | cellular response to topologically incorrect protein (GO:0035967) | 2.04650819 |
| 161 | response to muramyl dipeptide (GO:0032495) | 2.04476699 |
| 162 | stress fiber assembly (GO:0043149) | 2.03984968 |
| 163 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.03937124 |
| 164 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.03198122 |
| 165 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.02388814 |
| 166 | negative regulation of interleukin-8 production (GO:0032717) | 2.01799634 |
| 167 | collagen fibril organization (GO:0030199) | 2.01695922 |
| 168 | COPII vesicle coating (GO:0048208) | 1.99583833 |
| 169 | regulation of phospholipase A2 activity (GO:0032429) | 1.97588610 |
| 170 | regulation of natural killer cell differentiation (GO:0032823) | 1.96627269 |
| 171 | detection of other organism (GO:0098543) | 1.95709773 |
| 172 | regulation of early endosome to late endosome transport (GO:2000641) | 1.95311950 |
| 173 | establishment of endothelial barrier (GO:0061028) | 1.93314469 |
| 174 | gland morphogenesis (GO:0022612) | 1.93290481 |
| 175 | epidermal cell differentiation (GO:0009913) | 1.93261628 |
| 176 | endodermal cell differentiation (GO:0035987) | 1.91808542 |
| 177 | negative regulation of glycoprotein metabolic process (GO:1903019) | 1.91066959 |
| 178 | detection of bacterium (GO:0016045) | 1.91012104 |
| 179 | phagosome maturation (GO:0090382) | 1.90850546 |
| 180 | protein localization to endosome (GO:0036010) | 1.88732652 |
| 181 | sequestering of metal ion (GO:0051238) | 1.88727579 |
| 182 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 1.88237462 |
| 183 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 1.87628277 |
| 184 | transferrin transport (GO:0033572) | 1.87379892 |
| 185 | cellular response to nutrient (GO:0031670) | 1.87267284 |
| 186 | hair cycle (GO:0042633) | 1.86137434 |
| 187 | molting cycle (GO:0042303) | 1.86137434 |
| 188 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 1.85741622 |
| 189 | negative regulation of membrane potential (GO:0045837) | 1.85328718 |
| 190 | regulation of vitamin metabolic process (GO:0030656) | 1.85009524 |
| 191 | signal peptide processing (GO:0006465) | 1.84775969 |
| 192 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.84462577 |
| 193 | adhesion of symbiont to host cell (GO:0044650) | 1.84273739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.17759345 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.26662630 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.21074359 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79557260 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.63794871 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37363434 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15559913 |
| 8 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93054954 |
| 9 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91664150 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90881090 |
| 11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.87742171 |
| 12 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86349408 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86072372 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.82413550 |
| 15 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.81449513 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79863982 |
| 17 | CJUN_26792858_Chip-Seq_BT549_Human | 1.79700343 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77671958 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 1.77269036 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71047912 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70780075 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69792152 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69059858 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68974513 |
| 25 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.65942508 |
| 26 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.65942508 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65782475 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65654932 |
| 29 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65021965 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64781138 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60779926 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.59738118 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.59738118 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59504438 |
| 35 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59491488 |
| 36 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58751351 |
| 37 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.58667608 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58448114 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56345196 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56229178 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54259638 |
| 42 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.51616256 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.50571593 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48228686 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48025274 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.45082632 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44977541 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43392070 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42833262 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.41740419 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38767995 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 1.37766813 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36733267 |
| 54 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.35388386 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34239636 |
| 56 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30519536 |
| 57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27611674 |
| 58 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27193811 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27006076 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26760352 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25815973 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25585492 |
| 63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24459728 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.24148936 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23959746 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.23913872 |
| 67 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23842551 |
| 68 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21615014 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.21180767 |
| 70 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.20920588 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20128801 |
| 72 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19624929 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18972590 |
| 74 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18922813 |
| 75 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17848070 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16768936 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15480978 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15434815 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15170544 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14860060 |
| 81 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.14420907 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13351135 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13097917 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12933575 |
| 85 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12923388 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12266543 |
| 87 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11032085 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10795826 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10250536 |
| 90 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09834217 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09360413 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08729919 |
| 93 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08492883 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07627270 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06042714 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05832281 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05757012 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05499794 |
| 99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03881376 |
| 100 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02752715 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00705349 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00057430 |
| 103 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99564718 |
| 104 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98641962 |
| 105 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98395810 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97838665 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97287987 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96478372 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96112242 |
| 110 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95743751 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95339705 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94989342 |
| 113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94541506 |
| 114 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.94201133 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93598197 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92608030 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91911563 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91555758 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91400953 |
| 120 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90144346 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.89956544 |
| 122 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89792975 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89422187 |
| 124 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88478144 |
| 125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88208618 |
| 126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88138339 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87945608 |
| 128 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87764496 |
| 129 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85779064 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85026948 |
| 131 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84116682 |
| 132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.84116125 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83060275 |
| 134 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83060275 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82974523 |
| 136 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81794553 |
| 137 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81437214 |
| 138 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80840968 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80445640 |
| 140 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.80022635 |
| 141 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.79789514 |
| 142 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.79589317 |
| 143 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78721167 |
| 144 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.77778002 |
| 145 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.77027966 |
| 146 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76776528 |
| 147 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.75930771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005275_abnormal_skin_tensile | 4.28583003 |
| 2 | MP0002796_impaired_skin_barrier | 3.64933854 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.39827632 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.00084445 |
| 5 | MP0008260_abnormal_autophagy | 2.98000539 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.74461041 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.73447996 |
| 8 | MP0004947_skin_inflammation | 2.63663555 |
| 9 | MP0002060_abnormal_skin_morphology | 2.57300240 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.22263680 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.22093137 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.19857550 |
| 13 | MP0000685_abnormal_immune_system | 2.09907258 |
| 14 | MP0005025_abnormal_response_to | 2.07803825 |
| 15 | MP0003724_increased_susceptibility_to | 2.07464320 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.04994735 |
| 17 | MP0003656_abnormal_erythrocyte_physiolo | 2.01244244 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.95907197 |
| 19 | MP0003279_aneurysm | 1.94101536 |
| 20 | MP0001958_emphysema | 1.92290840 |
| 21 | MP0005387_immune_system_phenotype | 1.87911689 |
| 22 | MP0001790_abnormal_immune_system | 1.87911689 |
| 23 | MP0003941_abnormal_skin_development | 1.86917043 |
| 24 | MP0001800_abnormal_humoral_immune | 1.85484513 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 1.82161561 |
| 26 | MP0005501_abnormal_skin_physiology | 1.80162462 |
| 27 | MP0002723_abnormal_immune_serum | 1.77831739 |
| 28 | MP0006082_CNS_inflammation | 1.75589341 |
| 29 | MP0001216_abnormal_epidermal_layer | 1.73910819 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.73243179 |
| 31 | MP0004858_abnormal_nervous_system | 1.73237319 |
| 32 | MP0004510_myositis | 1.70082775 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.68341939 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.68173095 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.68073275 |
| 36 | MP0009840_abnormal_foam_cell | 1.66983282 |
| 37 | MP0001819_abnormal_immune_cell | 1.66096385 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.64841014 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.64635853 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.60641208 |
| 41 | MP0010771_integument_phenotype | 1.60588535 |
| 42 | MP0003436_decreased_susceptibility_to | 1.60529073 |
| 43 | MP0003195_calcinosis | 1.58397053 |
| 44 | MP0002405_respiratory_system_inflammati | 1.58219863 |
| 45 | MP0009278_abnormal_bone_marrow | 1.57026615 |
| 46 | MP0006054_spinal_hemorrhage | 1.56793484 |
| 47 | MP0002009_preneoplasia | 1.56264206 |
| 48 | MP0003303_peritoneal_inflammation | 1.53311472 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.52686843 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.45717716 |
| 51 | MP0004883_abnormal_blood_vessel | 1.45289843 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.44982863 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.44982863 |
| 54 | MP0008004_abnormal_stomach_pH | 1.43015635 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.42933606 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.38486388 |
| 57 | MP0005671_abnormal_response_to | 1.34401251 |
| 58 | MP0002295_abnormal_pulmonary_circulatio | 1.33666230 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.33653416 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.31234972 |
| 61 | MP0000343_altered_response_to | 1.30321717 |
| 62 | MP0002332_abnormal_exercise_endurance | 1.29662635 |
| 63 | MP0000569_abnormal_digit_pigmentation | 1.26764633 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.25554158 |
| 65 | MP0002398_abnormal_bone_marrow | 1.25034746 |
| 66 | MP0001542_abnormal_bone_strength | 1.23663433 |
| 67 | MP0005023_abnormal_wound_healing | 1.21927807 |
| 68 | MP0000716_abnormal_immune_system | 1.21085449 |
| 69 | MP0001243_abnormal_dermal_layer | 1.20987887 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.20697317 |
| 71 | MP0009384_cardiac_valve_regurgitation | 1.19320119 |
| 72 | MP0002132_abnormal_respiratory_system | 1.18378127 |
| 73 | MP0004381_abnormal_hair_follicle | 1.18303143 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.17213643 |
| 75 | MP0005503_abnormal_tendon_morphology | 1.15790977 |
| 76 | MP0001191_abnormal_skin_condition | 1.15257306 |
| 77 | MP0009764_decreased_sensitivity_to | 1.14752137 |
| 78 | MP0005451_abnormal_body_composition | 1.12899265 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.12742278 |
| 80 | MP0001851_eye_inflammation | 1.12509325 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 1.11987507 |
| 82 | MP0005390_skeleton_phenotype | 1.08467666 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.08118301 |
| 84 | MP0005257_abnormal_intraocular_pressure | 1.07854275 |
| 85 | MP0003828_pulmonary_edema | 1.07204190 |
| 86 | MP0008469_abnormal_protein_level | 1.06463268 |
| 87 | MP0002722_abnormal_immune_system | 1.05289074 |
| 88 | MP0003091_abnormal_cell_migration | 1.04006495 |
| 89 | MP0002933_joint_inflammation | 1.03892179 |
| 90 | MP0004272_abnormal_basement_membrane | 1.03082679 |
| 91 | MP0001765_abnormal_ion_homeostasis | 1.02171486 |
| 92 | MP0003075_altered_response_to | 1.01975535 |
| 93 | MP0002254_reproductive_system_inflammat | 1.01850480 |
| 94 | MP0009931_abnormal_skin_appearance | 1.01773505 |
| 95 | MP0003283_abnormal_digestive_organ | 1.01730437 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 1.00611791 |
| 97 | MP0003795_abnormal_bone_structure | 1.00445160 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 0.98638170 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.98380787 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98025502 |
| 101 | MP0000689_abnormal_spleen_morphology | 0.97903841 |
| 102 | MP0003690_abnormal_glial_cell | 0.97556669 |
| 103 | MP0000579_abnormal_nail_morphology | 0.96731579 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.96648394 |
| 105 | MP0003045_fibrosis | 0.96043989 |
| 106 | MP0005166_decreased_susceptibility_to | 0.95475551 |
| 107 | MP0009785_altered_susceptibility_to | 0.95467986 |
| 108 | MP0002429_abnormal_blood_cell | 0.95032463 |
| 109 | MP0002419_abnormal_innate_immunity | 0.94404496 |
| 110 | MP0004484_altered_response_of | 0.93923001 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.91836963 |
| 112 | MP0005310_abnormal_salivary_gland | 0.91815594 |
| 113 | MP0002006_tumorigenesis | 0.91633216 |
| 114 | MP0003448_altered_tumor_morphology | 0.91552905 |
| 115 | MP0003172_abnormal_lysosome_physiology | 0.91200820 |
| 116 | MP0005083_abnormal_biliary_tract | 0.90666409 |
| 117 | MP0000427_abnormal_hair_cycle | 0.90628393 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.87405223 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.87354905 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.86890018 |
| 121 | MP0002166_altered_tumor_susceptibility | 0.86305107 |
| 122 | MP0000249_abnormal_blood_vessel | 0.86293711 |
| 123 | MP0005000_abnormal_immune_tolerance | 0.85350049 |
| 124 | MP0003866_abnormal_defecation | 0.85090041 |
| 125 | MP0000015_abnormal_ear_pigmentation | 0.82881864 |
| 126 | MP0002735_abnormal_chemical_nociception | 0.82636349 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.82537158 |
| 128 | MP0005508_abnormal_skeleton_morphology | 0.82527640 |
| 129 | MP0005388_respiratory_system_phenotype | 0.81242353 |
| 130 | MP0002133_abnormal_respiratory_system | 0.81242353 |
| 131 | MP0005164_abnormal_response_to | 0.80684758 |
| 132 | MP0001756_abnormal_urination | 0.80003162 |
| 133 | MP0003329_amyloid_beta_deposits | 0.79110466 |
| 134 | MP0000367_abnormal_coat/_hair | 0.78745261 |
| 135 | MP0008874_decreased_physiological_sensi | 0.77959022 |
| 136 | MP0000858_altered_metastatic_potential | 0.76855891 |
| 137 | MP0000767_abnormal_smooth_muscle | 0.76440053 |
| 138 | MP0002972_abnormal_cardiac_muscle | 0.75928020 |
| 139 | MP0005409_darkened_coat_color | 0.75884914 |
| 140 | MP0005165_increased_susceptibility_to | 0.75276160 |
| 141 | MP0003950_abnormal_plasma_membrane | 0.74779025 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.74380415 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.73861837 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.73406163 |
| 145 | MP0000377_abnormal_hair_follicle | 0.72883511 |
| 146 | MP0001853_heart_inflammation | 0.72701255 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.70638722 |
| 148 | MP0000750_abnormal_muscle_regeneration | 0.69852637 |
| 149 | MP0005595_abnormal_vascular_smooth | 0.68441662 |
| 150 | MP0000604_amyloidosis | 0.67682893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.06976468 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.02084500 |
| 3 | Orchitis (HP:0100796) | 4.00715187 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.96439310 |
| 5 | Premature rupture of membranes (HP:0001788) | 3.92556571 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.82862387 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.67082295 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.63544933 |
| 9 | Optic neuritis (HP:0100653) | 3.63544933 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.62776773 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.53887266 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.48559974 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 3.47453500 |
| 14 | Increased IgE level (HP:0003212) | 3.25704182 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.23384933 |
| 16 | Stomatitis (HP:0010280) | 3.23137015 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.12700233 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11326285 |
| 19 | Atrophic scars (HP:0001075) | 3.10920383 |
| 20 | Gingivitis (HP:0000230) | 2.92948065 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 2.92598293 |
| 22 | Eczematoid dermatitis (HP:0000976) | 2.90222724 |
| 23 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.89814564 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 2.87795862 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.83555423 |
| 26 | Hypotrichosis (HP:0001006) | 2.81539429 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.80513366 |
| 28 | Increased connective tissue (HP:0009025) | 2.79250908 |
| 29 | Amyloidosis (HP:0011034) | 2.78271058 |
| 30 | Urticaria (HP:0001025) | 2.72108200 |
| 31 | Gingival bleeding (HP:0000225) | 2.71208584 |
| 32 | Aortic aneurysm (HP:0004942) | 2.70623551 |
| 33 | Abnormality of the peritoneum (HP:0002585) | 2.66480123 |
| 34 | Keratoconjunctivitis (HP:0001096) | 2.60988665 |
| 35 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.58779452 |
| 36 | Peritonitis (HP:0002586) | 2.56364898 |
| 37 | Recurrent skin infections (HP:0001581) | 2.56048354 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.53367308 |
| 39 | Cellulitis (HP:0100658) | 2.53007791 |
| 40 | Episodic fever (HP:0001954) | 2.52655029 |
| 41 | Fragile skin (HP:0001030) | 2.51857090 |
| 42 | Recurrent fungal infections (HP:0002841) | 2.50524622 |
| 43 | Dilatation of the ascending aorta (HP:0005111) | 2.47664536 |
| 44 | Polycythemia (HP:0001901) | 2.47516385 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.47455014 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.43576103 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.41447911 |
| 48 | Palmoplantar hyperkeratosis (HP:0000972) | 2.41368351 |
| 49 | Epistaxis (HP:0000421) | 2.34638514 |
| 50 | Natal tooth (HP:0000695) | 2.34453822 |
| 51 | Plantar hyperkeratosis (HP:0007556) | 2.34054950 |
| 52 | Ulnar claw (HP:0001178) | 2.32150594 |
| 53 | Short nail (HP:0001799) | 2.29215852 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.29056217 |
| 55 | Vascular tortuosity (HP:0004948) | 2.27345689 |
| 56 | Vasculitis (HP:0002633) | 2.26230497 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23528723 |
| 58 | Pustule (HP:0200039) | 2.23409455 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.22408828 |
| 60 | Hand muscle atrophy (HP:0009130) | 2.21552491 |
| 61 | Aortic dissection (HP:0002647) | 2.20975116 |
| 62 | Spondylolisthesis (HP:0003302) | 2.20526162 |
| 63 | Tetraparesis (HP:0002273) | 2.19848652 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.19202832 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19202832 |
| 66 | Beaking of vertebral bodies (HP:0004568) | 2.17653358 |
| 67 | Advanced eruption of teeth (HP:0006288) | 2.16387763 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.15996867 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 2.14314342 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.14314342 |
| 71 | Meningitis (HP:0001287) | 2.14117205 |
| 72 | T lymphocytopenia (HP:0005403) | 2.13652434 |
| 73 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13426950 |
| 74 | Palmar hyperkeratosis (HP:0010765) | 2.13029953 |
| 75 | Obstructive lung disease (HP:0006536) | 2.11501232 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11501232 |
| 77 | Hyporeflexia of lower limbs (HP:0002600) | 2.10286396 |
| 78 | Cervical subluxation (HP:0003308) | 2.10089067 |
| 79 | Chest pain (HP:0100749) | 2.09112881 |
| 80 | Arterial thrombosis (HP:0004420) | 2.09111859 |
| 81 | Wormian bones (HP:0002645) | 2.08723810 |
| 82 | Thick nail (HP:0001805) | 2.08708032 |
| 83 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08328388 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07704508 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07704508 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07704508 |
| 87 | Gangrene (HP:0100758) | 2.07098376 |
| 88 | Erythema (HP:0010783) | 2.06234471 |
| 89 | Type 1 muscle fiber predominance (HP:0003803) | 2.05875527 |
| 90 | Thin bony cortex (HP:0002753) | 2.04773524 |
| 91 | Long toe (HP:0010511) | 2.04632350 |
| 92 | Milia (HP:0001056) | 2.04398386 |
| 93 | Hypochromic anemia (HP:0001931) | 2.04163575 |
| 94 | Soft skin (HP:0000977) | 2.04053442 |
| 95 | Abnormality of T cell number (HP:0011839) | 2.02042799 |
| 96 | Difficulty climbing stairs (HP:0003551) | 2.01886755 |
| 97 | Distal lower limb amyotrophy (HP:0008944) | 2.01779391 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.01098422 |
| 99 | Hemoptysis (HP:0002105) | 1.99435873 |
| 100 | Loss of speech (HP:0002371) | 1.98965775 |
| 101 | Abnormality of nail color (HP:0100643) | 1.98342909 |
| 102 | Bradycardia (HP:0001662) | 1.97815075 |
| 103 | Arterial tortuosity (HP:0005116) | 1.96769001 |
| 104 | Hypercortisolism (HP:0001578) | 1.95984121 |
| 105 | Glomerulopathy (HP:0100820) | 1.95428782 |
| 106 | Spinal rigidity (HP:0003306) | 1.95124780 |
| 107 | Hyperglycemia (HP:0003074) | 1.95017656 |
| 108 | Myocardial infarction (HP:0001658) | 1.94542559 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 1.93487611 |
| 110 | Hydroxyprolinuria (HP:0003080) | 1.93487611 |
| 111 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91274191 |
| 112 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91274191 |
| 113 | Alopecia of scalp (HP:0002293) | 1.90654310 |
| 114 | Leukocytosis (HP:0001974) | 1.89617595 |
| 115 | Axonal loss (HP:0003447) | 1.89053390 |
| 116 | Microcytic anemia (HP:0001935) | 1.88648012 |
| 117 | Acanthosis nigricans (HP:0000956) | 1.87650525 |
| 118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87480111 |
| 119 | Osteomyelitis (HP:0002754) | 1.87057687 |
| 120 | Facial diplegia (HP:0001349) | 1.85854544 |
| 121 | Lip pit (HP:0100267) | 1.85435065 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.82997775 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 1.81360189 |
| 124 | Increased CSF protein (HP:0002922) | 1.81319184 |
| 125 | Conjunctival hamartoma (HP:0100780) | 1.78762223 |
| 126 | Curly hair (HP:0002212) | 1.78738750 |
| 127 | Ovoid vertebral bodies (HP:0003300) | 1.78632851 |
| 128 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.77800655 |
| 129 | Aneurysm (HP:0002617) | 1.77625499 |
| 130 | Skin ulcer (HP:0200042) | 1.76798669 |
| 131 | Ulnar deviation of the wrist (HP:0003049) | 1.76174305 |
| 132 | Bruising susceptibility (HP:0000978) | 1.76137006 |
| 133 | Persistence of primary teeth (HP:0006335) | 1.75586949 |
| 134 | Encephalitis (HP:0002383) | 1.75400720 |
| 135 | Hematochezia (HP:0002573) | 1.74720505 |
| 136 | Joint stiffness (HP:0001387) | 1.74532961 |
| 137 | Glucose intolerance (HP:0000833) | 1.74202873 |
| 138 | Inflammation of the large intestine (HP:0002037) | 1.74014346 |
| 139 | Woolly hair (HP:0002224) | 1.73532539 |
| 140 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.73455400 |
| 141 | Abnormality of the pericardium (HP:0001697) | 1.73387994 |
| 142 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72135337 |
| 143 | Lower limb amyotrophy (HP:0007210) | 1.71724040 |
| 144 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71148590 |
| 145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71148590 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71148590 |
| 147 | Pulmonary embolism (HP:0002204) | 1.71138214 |
| 148 | Achilles tendon contracture (HP:0001771) | 1.70973838 |
| 149 | Ventricular tachycardia (HP:0004756) | 1.70177247 |
| 150 | Abnormal platelet volume (HP:0011876) | 1.69869572 |
| 151 | Upper limb muscle weakness (HP:0003484) | 1.69635694 |
| 152 | Recurrent viral infections (HP:0004429) | 1.68954752 |
| 153 | Subacute progressive viral hepatitis (HP:0006572) | 1.68935557 |
| 154 | Anhidrosis (HP:0000970) | 1.68935543 |
| 155 | Striae distensae (HP:0001065) | 1.68370511 |
| 156 | Gastrointestinal inflammation (HP:0004386) | 1.67748880 |
| 157 | Scapular winging (HP:0003691) | 1.67692624 |
| 158 | Coxa vara (HP:0002812) | 1.67094087 |
| 159 | Cerebral inclusion bodies (HP:0100314) | 1.67027533 |
| 160 | Hyperextensible skin (HP:0000974) | 1.65768607 |
| 161 | Sepsis (HP:0100806) | 1.64595587 |
| 162 | Onycholysis (HP:0001806) | 1.64511289 |
| 163 | Hyperparathyroidism (HP:0000843) | 1.63953305 |
| 164 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.63888851 |
| 165 | Hoarse voice (HP:0001609) | 1.63704887 |
| 166 | Genu recurvatum (HP:0002816) | 1.63660134 |
| 167 | Visual hallucinations (HP:0002367) | 1.63622611 |
| 168 | Menorrhagia (HP:0000132) | 1.63083531 |
| 169 | Asymmetric septal hypertrophy (HP:0001670) | 1.62998630 |
| 170 | Onion bulb formation (HP:0003383) | 1.62292746 |
| 171 | Osteopenia (HP:0000938) | 1.61998788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPKAPK3 | 3.00550760 |
| 2 | ERN1 | 2.96993713 |
| 3 | MAP3K3 | 2.92406129 |
| 4 | EPHA3 | 2.85038486 |
| 5 | PRPF4B | 2.81185150 |
| 6 | MAP3K9 | 2.27653940 |
| 7 | FER | 2.25728595 |
| 8 | IRAK4 | 2.09456789 |
| 9 | MAP3K2 | 2.04986757 |
| 10 | TIE1 | 2.04907402 |
| 11 | CSK | 1.91343644 |
| 12 | MAP4K1 | 1.86713677 |
| 13 | TRIB3 | 1.77345796 |
| 14 | MST1R | 1.75985259 |
| 15 | MAP3K12 | 1.73971143 |
| 16 | GRK6 | 1.72508603 |
| 17 | MAP2K3 | 1.71587857 |
| 18 | FES | 1.71530470 |
| 19 | ERBB3 | 1.70736271 |
| 20 | MAP3K1 | 1.70474659 |
| 21 | TAOK1 | 1.68668491 |
| 22 | TBK1 | 1.65730687 |
| 23 | RIPK1 | 1.61624424 |
| 24 | NTRK1 | 1.55800376 |
| 25 | TAOK2 | 1.47806441 |
| 26 | TGFBR2 | 1.45519099 |
| 27 | RIPK4 | 1.45432674 |
| 28 | MST4 | 1.42288400 |
| 29 | CDK12 | 1.41162996 |
| 30 | PRKD3 | 1.41148625 |
| 31 | FGR | 1.39949258 |
| 32 | KSR2 | 1.39858542 |
| 33 | MARK2 | 1.38866125 |
| 34 | MAP3K14 | 1.37285282 |
| 35 | MAPK15 | 1.33730454 |
| 36 | MAP3K6 | 1.33652969 |
| 37 | TTN | 1.32876785 |
| 38 | WNK1 | 1.28381815 |
| 39 | MAP3K13 | 1.26377372 |
| 40 | HCK | 1.21717092 |
| 41 | LATS2 | 1.21118219 |
| 42 | TRPM7 | 1.20504757 |
| 43 | TESK1 | 1.20029211 |
| 44 | CAMKK2 | 1.15496791 |
| 45 | CDC42BPA | 1.15385048 |
| 46 | FGFR4 | 1.14263343 |
| 47 | MAP3K11 | 1.13279201 |
| 48 | DDR2 | 1.10634127 |
| 49 | PIM2 | 1.08669565 |
| 50 | MAP2K1 | 1.08527147 |
| 51 | MOS | 1.05994667 |
| 52 | INSRR | 1.05793426 |
| 53 | PTK2 | 1.04298854 |
| 54 | EPHB1 | 1.04247255 |
| 55 | IRAK3 | 1.02860467 |
| 56 | BMPR2 | 1.02744092 |
| 57 | RAF1 | 1.01820167 |
| 58 | AKT3 | 1.01176002 |
| 59 | PDGFRA | 1.00620472 |
| 60 | MINK1 | 0.97221308 |
| 61 | PDK1 | 0.97051715 |
| 62 | SYK | 0.96652098 |
| 63 | TXK | 0.96178917 |
| 64 | RET | 0.95953194 |
| 65 | EPHB2 | 0.95518378 |
| 66 | TNK2 | 0.93474672 |
| 67 | BTK | 0.93466235 |
| 68 | WNK4 | 0.93173131 |
| 69 | TAOK3 | 0.93083246 |
| 70 | SIK3 | 0.92562045 |
| 71 | PAK3 | 0.90711945 |
| 72 | BMX | 0.90143889 |
| 73 | SGK3 | 0.89931690 |
| 74 | IRAK1 | 0.88060532 |
| 75 | MAP2K2 | 0.85103161 |
| 76 | PRKD2 | 0.83362207 |
| 77 | JAK1 | 0.82211821 |
| 78 | CAMKK1 | 0.81514073 |
| 79 | JAK3 | 0.81143821 |
| 80 | ARAF | 0.80455886 |
| 81 | NTRK3 | 0.79713341 |
| 82 | IRAK2 | 0.77422513 |
| 83 | MAPK12 | 0.76430435 |
| 84 | FRK | 0.75579163 |
| 85 | HIPK2 | 0.74137137 |
| 86 | MAP2K4 | 0.74050804 |
| 87 | NEK9 | 0.73838328 |
| 88 | MAPK7 | 0.72973624 |
| 89 | IKBKE | 0.72244162 |
| 90 | PIK3CA | 0.71655650 |
| 91 | IKBKB | 0.71300170 |
| 92 | BRD4 | 0.71053838 |
| 93 | MAP3K7 | 0.70641502 |
| 94 | ICK | 0.69869397 |
| 95 | PRKG2 | 0.69631655 |
| 96 | KSR1 | 0.69517753 |
| 97 | LYN | 0.68207194 |
| 98 | PTK6 | 0.68013203 |
| 99 | MYLK | 0.67911346 |
| 100 | MARK3 | 0.67512476 |
| 101 | SIK2 | 0.67205222 |
| 102 | LCK | 0.66753114 |
| 103 | SCYL2 | 0.66605618 |
| 104 | MAP3K5 | 0.64773640 |
| 105 | FGFR3 | 0.64744086 |
| 106 | CHUK | 0.63710282 |
| 107 | DAPK2 | 0.63675866 |
| 108 | PAK6 | 0.63597105 |
| 109 | PRKCE | 0.63153717 |
| 110 | WNK3 | 0.61984032 |
| 111 | MAPKAPK5 | 0.61929008 |
| 112 | LIMK1 | 0.61873395 |
| 113 | TESK2 | 0.61767556 |
| 114 | STK24 | 0.61317998 |
| 115 | TYK2 | 0.60956645 |
| 116 | PIK3CG | 0.60809378 |
| 117 | PDK2 | 0.60315241 |
| 118 | SGK2 | 0.59768858 |
| 119 | YES1 | 0.59766078 |
| 120 | MATK | 0.59382375 |
| 121 | ZAP70 | 0.58673419 |
| 122 | TEC | 0.58516552 |
| 123 | LRRK2 | 0.58403649 |
| 124 | STK10 | 0.58030824 |
| 125 | DYRK1B | 0.54232510 |
| 126 | RPS6KA4 | 0.54087411 |
| 127 | SIK1 | 0.53925431 |
| 128 | KDR | 0.53721953 |
| 129 | PRKCH | 0.52993848 |
| 130 | KIT | 0.52538116 |
| 131 | GRK5 | 0.52358555 |
| 132 | PDPK1 | 0.49841379 |
| 133 | JAK2 | 0.49123604 |
| 134 | RPS6KA2 | 0.48684053 |
| 135 | PTK2B | 0.48627875 |
| 136 | STK38 | 0.46086955 |
| 137 | SGK494 | 0.45971353 |
| 138 | SGK223 | 0.45971353 |
| 139 | BLK | 0.45095233 |
| 140 | GRK7 | 0.44998768 |
| 141 | ABL2 | 0.44894200 |
| 142 | FYN | 0.44425604 |
| 143 | ITK | 0.42471934 |
| 144 | PRKD1 | 0.40427859 |
| 145 | PRKAA2 | 0.40296187 |
| 146 | MAPKAPK2 | 0.39991055 |
| 147 | PDGFRB | 0.35922306 |
| 148 | MAP2K6 | 0.35741737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74407884 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72977698 |
| 3 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71397162 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 1.70681090 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66757490 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.64218342 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62143034 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61699710 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.60893940 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51642112 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47299284 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45907061 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44485106 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42866452 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41385446 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.34026660 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33292624 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30743745 |
| 19 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.28406325 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.25414222 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.23708693 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22980526 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22827522 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.21473211 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.18725636 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.17922122 |
| 27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.17834557 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17731934 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.17131735 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.16716251 |
| 31 | Amoebiasis_Homo sapiens_hsa05146 | 1.16363600 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.15370437 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.14695006 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13807777 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.13701647 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12695991 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11468428 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10164800 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08092084 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07900503 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06944197 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06154457 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04575513 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03219633 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01596133 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01129744 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00415833 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.98613376 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97992049 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97921969 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97374011 |
| 52 | Focal adhesion_Homo sapiens_hsa04510 | 0.95773524 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94776379 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94335504 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.92330983 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91076049 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90115937 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89702002 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89330562 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.89060591 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88645962 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88550616 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88537645 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87601642 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.87082018 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86794437 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85508624 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.85191902 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84338354 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83764035 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83059501 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82964495 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.82762956 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82584659 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82003038 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81945916 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81333899 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80227792 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80212555 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79091344 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.78780908 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77855191 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.77757884 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76675282 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.76644927 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76640025 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75823682 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.75720768 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74833427 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.74333137 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73817589 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.73344823 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72483783 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.71458328 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71249591 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71153811 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70949073 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70109572 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.69250174 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68983200 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68714723 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68661059 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68601284 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66735733 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66329257 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66007427 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.65754751 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64996928 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64910261 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63398103 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.63189035 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62848885 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62777399 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62549939 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62016232 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.61754262 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61332243 |
| 118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61301200 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.61198023 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60626287 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60470642 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58912577 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58392011 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58158459 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56904669 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56655554 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.56569990 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56333435 |
| 129 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55374040 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55290761 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55165238 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54947649 |
| 133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53066709 |
| 134 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48785023 |

